IP Library Granted Patent US 12,383,224
Granted Patent B2
US 12,383,224 · App. 18/539,139 · Granted Aug 12, 2025

Methods and systems for controlled deployment of needle structures in tissue

Inventors: Michael A. Munrow (Belmont, CA); Darrin Uecker (San Mateo, CA); Brian Placek (Menlo Park, CA); Harry Kwan (San Francisco, CA); David Toub (Wyncote, PA); Cameron D. Hinman (Thurmond, NC); David J. Danitz (San Jose, CA)
Assignee: Gynesonics, Inc.
A61B8/0841A61B5/066A61B8/12A61B8/445A61B8/463A61B18/1477A61B34/25A61B8/145A61B8/461A61B8/467A61B2018/00559A61B2018/00577A61B2018/00702A61B2018/00761A61B2018/00898A61B2018/00904A61B2018/00982A61B18/02A61B2018/0293A61B18/042A61B2018/143A61B2018/1475A61B18/1485A61B18/1815A61B2034/104A61B2034/107A61B2034/2063A61B2034/254A61B2090/034A61B90/04A61B2090/0427A61B2090/378A61B2090/3782A61B2090/3784A61N2007/025F04C2270/041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,224
App. No.
18/539,139
Granted
Aug 12, 2025
Kind
B2
Abstract

A system for deploying needles in tissue includes a controller and a visual display. A treatment probe has both a needle and tines deployable from the needle which may be advanced into the tissue. The treatment probe also has adjustable stops which control the deployed positions of both the needle and the tines. The adjustable stops are coupled to the controller so that the virtual treatment and safety boundaries resulting from the treatment can be presented on the visual display prior to actual deployment of the system.

Claims (28)

1. A system for deploying a plurality of tines from a needle in tissue, the system comprising:

a display; and

a controller operatively coupled to the display, the controller being provided with instructions to:

provide, via the display, a real-time image of the tissue including an anatomical feature to be treated, and

project at least one of a treatment boundary or a safety boundary onto the display,

wherein the safety boundary comprises a minimum threshold distance beyond the treatment boundary where a risk of damaging tissue during the treatment is reduced;

wherein the needle is configured to penetrate into the tissue proximate the anatomical feature to be treated,

wherein the plurality of tines is configured to be deployed from the needle, wherein an extent of tine deployment is adjustable to change one or more of a size or shape of one or more of the treatment or safety boundary projected onto the display;

wherein the controller is operable to deliver treatment to the anatomical feature to be treated through the plurality of tines after adjusting the extent of tine deployment.

2. The system of claim 1 , further comprising a treatment probe, wherein the treatment probe comprises a needle component comprising the needle and the plurality of tines deployable from the needle.

3. The system of claim 2 , further comprising a radiofrequency energy generator coupled to the needle component, wherein the treatment delivered comprises radiofrequency energy generated by the radiofrequency generator.

4. The system of claim 2 , wherein the treatment probe further comprises an imaging component.

5. The system of claim 4 , wherein the imaging component is configured to capture the real-time image of the tissue including the anatomical feature to be treated.

6. The system of claim 4 , wherein the imaging component comprises an ultrasonic imaging transducer.

7. The system of claim 6 , wherein the ultrasonic imaging transducer is disposed at a distal end of the treatment probe.

8. The system of claim 7 , wherein the ultrasonic imaging transducer is pivotably disposed at a distal end of the treatment probe.

9. The system of claim 1 , wherein the treatment delivered comprises one or more of radiofrequency (RF) energy, microwave energy, a treatment plasma, heat, cold (cryogenic therapy), or any combination thereof.

10. The system of claim 2 , wherein the size of the treatment boundary is determined at least partially based on a planned extent of advancement of the plurality of tines from the needle and on a planned duration of application of radiofrequency energy applied to the needle.

11. The system of claim 2 , wherein the controller is operatively coupled to the display and the treatment probe.

12. The system of claim 1 , further comprising at least one sensor configured to track deployment of the plurality of tines.

13. The system of claim 12 , wherein the instructions provided to the controller further comprise instructions to project, onto the display, actual needle structure location information, wherein the actual needle structure location information is derived from the at least one sensor.

14. The system of claim 2 , wherein the controller is disposed on the treatment probe.

15. The system of claim 2 , further comprising a user interface connected to the controller, wherein the user interface is configured to one or more of a size or shape of one or more of the treatment or safety boundary.

16. The system of claim 15 , wherein the user interface is on the treatment probe.

17. The system of claim 2 , wherein the needle is configured to be deployed from the treatment probe prior to deploying the plurality of tines from the needle.

18. The system of claim 1 , wherein the instructions provided to the controller further comprise instructions for projecting, onto the display, virtual needle structure stop location information.

19. The system of claim 18 , wherein the virtual needle structure stop location information comprises markers representing locations on the needle and the plurality of tines after deployment.

20. The system of claim 2 , further comprising a second probe separate from the treatment probe, wherein the second probe comprises an imaging component.

Assignments (6)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE APPLICATION NUMBER FROM 17084141 TO 18539139 AND ATTORNEY DOCKET NUMBER FROM 31992-714.302 TO 31992-714.304 PREVIOUSLY RECORDED AT REEL: 68685 FRAME: 217. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 8, 2024
From: MUNROW, MICHAEL A.; UECKER, DARRIN; PLACEK, BRIAN; KWAN, HARRY; TOUB, DAVID; HINMAN, CAMERON D.; DANITZ, DAVID J.
To: GYNESONICS, INC.
Reel/Frame 069475/0622 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2024
From: MUNROW, MICHAEL A.; UECKER, DARRIN; PLACEK, BRIAN; KWAN, HARRY; TOUB, DAVID; HINMAN, CAMERON D.; DANITZ, DAVID J.
To: GYNESONICS, INC.
Reel/Frame 068685/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2024
From: MUNROW, MICHAEL A.; UECKER, DARRIN; PLACEK, BRIAN; KWAN, HARRY; TOUB, DAVID; HINMAN, CAMERON D.; DANITZ, DAVID J.
To: GYNESONICS, INC.
Reel/Frame 067076/0961 →
Continuity (5)
Continuation 17084141 · Oct 29, 2020
Continuation 15793874 · Oct 25, 2017
Continuation 13801782 · Mar 13, 2013
Provisional Application 61698196 · Sep 7, 2012
Related Publication 20240341719A1 · Oct 17, 2024
References Cited (149)
US 4742829A · Law et al. · 1988 [cited by applicant]
US 6050992A · Nichols · 2000 [cited by applicant]
US 6216029B1 · Paltieli · 2001 [cited by applicant]
US 6336899B1 · Yamazaki · 2002 [cited by applicant]
US 6540677B1 · Angelsen et al. · 2003 [cited by applicant]
US 6585694B1 · Smith et al. · 2003 [cited by applicant]
US 6623481B1 · Garbagnati et al. · 2003 [cited by applicant]
US 6936048B2 · Hurst · 2005 [cited by applicant]
US 6944490B1 · Chow · 2005 [cited by applicant]
US 6969354B1 · Marian · 2005 [cited by applicant]
US 7160296B2 · Pearson et al. · 2007 [cited by applicant]
US 7229401B2 · Kindlein · 2007 [cited by applicant]
US 7387628B1 · Behl et al. · 2008 [cited by applicant]
US 7517346B2 · Sloan et al. · 2009 [cited by applicant]
US 7815571B2 · Deckman et al. · 2010 [cited by applicant]
US 7874986B2 · Deckman et al. · 2011 [cited by applicant]
US 7918795B2 · Grossman · 2011 [cited by applicant]
US 7963941B2 · Wilk · 2011 [cited by applicant]
US 8080009B2 · Lee et al. · 2011 [cited by applicant]
US 8157741B2 · Hirota · 2012 [cited by applicant]
US 8157745B2 · Schoot · 2012 [cited by applicant]
US 8206300B2 · Deckman et al. · 2012 [cited by applicant]
US 8216231B2 · Behl et al. · 2012 [cited by applicant]
US 8221321B2 · McMorrow et al. · 2012 [cited by applicant]
US 8262574B2 · Placek et al. · 2012 [cited by applicant]
US 8287485B2 · Kimura et al. · 2012 [cited by applicant]
US 8377041B2 · Frassica et al. · 2013 [cited by applicant]
US 8469893B2 · Chiang et al. · 2013 [cited by applicant]
US 8512330B2 · Epstein et al. · 2013 [cited by applicant]
US 8512333B2 · Epstein et al. · 2013 [cited by applicant]
US 8540634B2 · Bruce et al. · 2013 [cited by applicant]
US 8585598B2 · Razzaque et al. · 2013 [cited by applicant]
US 8622911B2 · Hossack et al. · 2014 [cited by applicant]
US 8663130B2 · Neubach et al. · 2014 [cited by applicant]
US 8718339B2 · Tonomura et al. · 2014 [cited by applicant]
US 8814796B2 · Martin et al. · 2014 [cited by applicant]
US 8992427B2 · Munrow et al. · 2015 [cited by applicant]
US 9089287B2 · Sliwa et al. · 2015 [cited by applicant]
US 9198707B2 · McKay et al. · 2015 [cited by applicant]
US 9198719B2 · Murdeshwar et al. · 2015 [cited by applicant]
US 9247925B2 · Havel et al. · 2016 [cited by applicant]
US 9357977B2 · Grossman · 2016 [cited by applicant]
US 9439627B2 · Case et al. · 2016 [cited by applicant]
US 9510898B2 · Epstein et al. · 2016 [cited by applicant]
US 9516996B2 · Diolaiti et al. · 2016 [cited by applicant]
US 10856838B2 · Munrow et al. · 2020 [cited by applicant]
US 11583243B2 · Munrow et al. · 2023 [cited by applicant]
US 20020072742A1 · Schaefer et al. · 2002 [cited by applicant]
US 20030045768A1 · Hirooka et al. · 2003 [cited by applicant]
US 20030195502A1 · Garabedian et al. · 2003 [cited by applicant]
US 20050107781A1 · Ostrovsky et al. · 2005 [cited by applicant]
US 20060015115A1 · Haines · 2006 [cited by applicant]
US 20060178665A1 · Sloan et al. · 2006 [cited by applicant]
US 20060189972A1 · Grossman · 2006 [cited by applicant]
US 20060276811A1 · Copa et al. · 2006 [cited by applicant]
US 20060285637A1 · Varjonen et al. · 2006 [cited by applicant]
US 20060287579A1 · Okada · 2006 [cited by applicant]
US 20070006215A1 · Epstein et al. · 2007 [cited by applicant]
US 20070016183A1 · Lee et al. · 2007 [cited by applicant]
US 20070123797A1 · Krause · 2007 [cited by applicant]
US 20070167808A1 · Nozaki · 2007 [cited by applicant]
US 20070249939A1 · Gerbi et al. · 2007 [cited by applicant]
US 20080015664A1 · Podhajsky · 2008 [cited by applicant]
US 20080033493A1 · Deckman et al. · 2008 [cited by applicant]
US 20080228081A1 · Becker et al. · 2008 [cited by applicant]
US 20090043295A1 · Arnal et al. · 2009 [cited by applicant]
US 20090099544A1 · Munrow et al. · 2009 [cited by applicant]
US 20100056926A1 · Deckman et al. · 2010 [cited by applicant]
US 20100160787A1 · Gorzitze · 2010 [cited by applicant]
US 20100262133A1 · Hoey et al. · 2010 [cited by applicant]
US 20100268067A1 · Razzaque et al. · 2010 [cited by applicant]
US 20110046483A1 · Fuchs et al. · 2011 [cited by applicant]
US 20110046552A1 · Bankiewicz et al. · 2011 [cited by applicant]
US 20110238057A1 · Moss et al. · 2011 [cited by applicant]
US 20110288540A1 · Wright et al. · 2011 [cited by applicant]
US 20120035474A1 · Deckman et al. · 2012 [cited by applicant]
US 20120071794A1 · Karni · 2012 [cited by applicant]
US 20120165813A1 · Lee et al. · 2012 [cited by applicant]
US 20120209115A1 · Tonomura · 2012 [cited by applicant]
US 20120277737A1 · Curley · 2012 [cited by applicant]
US 20130281863A1 · Chiang et al. · 2013 [cited by applicant]
US 20130317366A1 · Hirayama et al. · 2013 [cited by applicant]
US 20140180273A1 · Nair · 2014 [cited by applicant]
US 20140276081A1 · Tegels · 2014 [cited by applicant]
US 20150150497A1 · Goldchmit · 2015 [cited by applicant]
US 20150173592A1 · Leeflang et al. · 2015 [cited by applicant]
US 20150257779A1 · Sinelnikov et al. · 2015 [cited by applicant]
US 20160030240A1 · Gonenc et al. · 2016 [cited by applicant]
US 20160151041A1 · Lee et al. · 2016 [cited by applicant]
US 20160278740A1 · Negrila et al. · 2016 [cited by applicant]
US 20160310042A1 · Kesten et al. · 2016 [cited by applicant]
US 20180042572A1 · Munrow et al. · 2018 [cited by applicant]
US 20180289430A1 · Kahya et al. · 2018 [cited by applicant]
US 20210186455A1 · Munrow et al. · 2021 [cited by applicant]
US 20210228179A1 · Munrow et al. · 2021 [cited by applicant]
CN 2936129Y · 2007 [cited by applicant]
CN 102449666A · 2012 [cited by applicant]
CN 102470013A · 2012 [cited by applicant]
EP 1649822A1 · 2006 [cited by applicant]
JP H01157713U · 1989 [cited by applicant]
JP H11508790A · 1999 [cited by applicant]
JP 2000342587A · 2000 [cited by applicant]
JP 2001340350A · 2001 [cited by applicant]
JP 2003534037A · 2003 [cited by applicant]
JP 2006513831A · 2006 [cited by applicant]
JP 2006346341A · 2006 [cited by applicant]
JP 2007215672A · 2007 [cited by applicant]
JP 2009022764A · 2009 [cited by applicant]
JP 2009526554A · 2009 [cited by applicant]
JP 2011500164A · 2011 [cited by applicant]
JP 2012519037A · 2012 [cited by applicant]
JP 6343648B2 · 2018 [cited by applicant]
RU 2012358C1 · 1994 [cited by applicant]
WO WO2004112446A1 · 2004 [cited by applicant]
WO WO2007149595A2 · 2007 [cited by applicant]
WO WO2009049082A1 · 2009 [cited by applicant]
WO WO2010027820A1 · 2010 [cited by applicant]
WO WO2010099481A1 · 2010 [cited by applicant]
WO WO2014039795A1 · 2014 [cited by applicant]
Bao et al., A prototype ultrasound-guided laparoscopic radiofrequency ablation system, Surgical Endoscopy, vol. 21, pp. 74-79 (2007), Epub Oct. 5, 2006. [cited by applicant]
CN Serial No. 201380058193X 2nd Office Action dated Apr. 21, 2017. [cited by applicant]
CN Serial No. 201380058193X 3rd Office Action dated Dec. 13, 2017. [cited by applicant]
CN Serial No. 201380058193X First Office Action dated Sep. 5, 2016. [cited by applicant]
CN Serial No. 2018107069877 1st Office Action dated Jul. 15, 2020. [cited by applicant]
CN Serial No. 2018107069877 2nd Office Action dated Mar. 31, 2021. [cited by applicant]
CN Serial No. 2018107069877 3rd Office Action dated Sep. 14, 2021. [cited by applicant]
EP13835274.5 Extended Search Report dated Jun. 2, 2016. [cited by applicant]
EP18172574.8 Extended Search Report dated Sep. 6, 2018. [cited by applicant]
International Search Report and Written Opinion dated Jan. 17, 2018 for International PCT Patent Application No. PCT/US2017/061366. [cited by applicant]
International search report and written opinion dated Dec. 11, 2013 for PCT/US2013/058467. [cited by applicant]
JP Serial No. 2015-531229 Office Action dated Jun. 23, 2017. [cited by applicant]
JP Serial No. 2017-217313 Final Office Action dated Feb. 28, 2019. [cited by applicant]
JP Serial No. 2017-217313 Office Action dated Aug. 31, 2018. [cited by applicant]
Notice of allowance dated Jan. 7, 2015 for U.S. Appl. No. 13/801,840. [cited by applicant]
Notice of allowance dated Oct. 19, 2020 for U.S. Appl. No. 15/793,874. [cited by applicant]
Office action dated Jul. 27, 2020 for U.S. Appl. No. 15/793,874. [cited by applicant]
Office action dated Aug. 29, 2013 for U.S. Appl. No. 13/801,840. [cited by applicant]
Office action dated Sep. 3, 2014 for U.S. Appl. No. 13/801,840. [cited by applicant]
Office action dated Nov. 25, 2013 for U.S. Appl. No. 13/801,840. [cited by applicant]
PCT/US2013/058467 International Preliminary Report on Patentability dated Mar. 10, 2013. [cited by applicant]
U.S. Appl. No. 13/801,782 Notice of Allowance dated Nov. 2, 2017. [cited by applicant]
U.S. Appl. No. 13/801,782 Office Action dated Apr. 10, 2017. [cited by applicant]
U.S. Appl. No. 13/801,782 Office Action dated Sep. 26, 2016. [cited by applicant]
U.S. Appl. No. 17/084,141 Notice of Allowance dated Sep. 27, 2023. [cited by applicant]
U.S. Appl. No. 17/084,141 Office Action dated Dec. 22, 2022. [cited by applicant]
U.S. Appl. No. 17/232,051 Notice of Allowance dated Oct. 26, 2022. [cited by applicant]
U.S. Appl. No. 17/232,051 Office Action dated Jun. 14, 2021. [cited by applicant]
U.S. Appl. No. 17/232,051 Office Action dated Apr. 18, 2022. [cited by applicant]
U.S. Appl. No. 17/232,051 Office Action dated Nov. 23, 2021. [cited by applicant]